June 28, 2022

Volume XII, Number 179

Advertisement
Advertisement

June 27, 2022

Subscribe to Latest Legal News and Analysis

Feeling Thirsty? Wall Street, Industry Giants Stir Renewed Interest in the CBD-Beverage Market

For several years, industry giants such as Coca-ColaPepsiCo, and Anheuser-Busch have made waves announcing future plans to explore the CBD-beverage market. And last week, Nasdaq published an article on the future of investment opportunities in cannabis-infused drinks. Perhaps most notable from the article was Nasdaq’s expected valuation for the CBD beverage market — a staggering $1.4 billion by 2023.

While it is true that certain investors are seeing green in the CBD-beverage market, the space is still plagued by a landmine of legal uncertainty and questions. Hemp-derived CBD was legalized at the federal level by the Agriculture Improvement Act of 2018, also known as the Farm Bill. However, as we previously discussed, the FDA and FTC have overlapping enforcement authority over the marketing of CBD products, which can include anything from food products to dietary supplements to beverages with CBD added. And as recently as November 16, 2021, the FDA reiterated that its approach to regulating the CBD industry will be same as it has been  — a regulatory minefield. The acting Deputy Center Director for Regulatory Policy at the FDA’s Center for Drug Evaluation and Research recently emphasized the agency’s position that it needs additional CBD research and safety data before it will consider CBD for uses beyond prescription drugs, including usage as a food or beverage additive or dietary supplement.

Companies marketing CBD beverages should take careful steps to ensure compliance with the FDA’s labeling requirements and guidance regarding CBD products. Unless and until the FDA provides further guidance, we can expect the back-and-forth game to continue with CBD companies entering the beverage space and the FDA initiating periodic enforcement actions. At a minimum, CBD companies entering the beverage space should refrain from making health claims, such as a product “can prevent, treat, or cure” a disease, as these claims are ripe for FDA enforcement actions. We provided several marketing dos and don’ts in a previous blog post that apply with equal force to the CBD beverage industry.

With industry experts claiming that the “best way to consume cannabinoids is through a beverage,” and Nasdaq reporting on the investment opportunities that surround CBD beverages, it is no surprise that CBD beverages are exploding in popularity. 

© 2022 Bradley Arant Boult Cummings LLPNational Law Review, Volume XII, Number 38
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Rachel L. Sodée Litigation Attorney Bradley Arant Boult Cummings Nashville
Associate

Rachel Sodée is an associate in Bradley’s Litigation Practice Group.

Rachel received her J.D. from Vanderbilt University Law School, where she was symposium editor for the Vanderbilt Law Review and president of the Labor and Employment Law Society. She earned a B.A. (summa cum laude) in French and English from the University of Alabama.

615-252-3872
Richard W. F. Swor IP Litigation Attorney Bradley Arant Boult Cummings LLP
Associate

Richard Swor is an associate in the Litigation and Intellectual Property practice groups. His practice focuses on complex business and commercial litigation, assisting clients at the trial court, appellate court, and administrative court levels. Richard has been involved in a wide variety of dispute subject matter areas, including pharmaceutical defense, construction, trademark, domain names, and local election laws.

His practice includes representing clients in trademark disputes, including at the Trademark Trial and Appeal Board (TTAB) in both...

615-252-2360
Advertisement
Advertisement
Advertisement